No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
KZR Kezar Life Sciences
- 0.772
- -0.004-0.50%
Close May 22 16:00 ET
- 0.761
- -0.011-1.37%
Pre 08:00 ET
56.20MMarket Cap-555P/E (TTM)
0.785High0.751Low208.33KVolume0.779Open0.776Pre Close159.73KTurnover0.40%Turnover RatioLossP/E (Static)72.80MShares3.13052wk High0.33P/B40.52MFloat Cap0.67552wk Low--Dividend TTM52.48MShs Float36.327Historical High--Div YieldTTM4.41%Amplitude0.675Historical Low0.766Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Hold Rating on Kezar Life Sciences Amid Trial Progress and Efficacy Concerns
Express News | Kezar Life Sciences Q1 EPS $(0.30) Beats $(0.33) Estimate
Kezar Life Sciences | 10-Q: Quarterly report
Press Release: Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update
Kezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update -- PALIZADE Phase 2b clinical trial of zetomipzomib in patients with active lupus nephritis act
Kezar Life Sciences 1Q Loss/Shr 30c >KZR
Kezar Life Sciences 1Q Loss/Shr 30c >KZR
Express News | Kezar Life Sciences Q1 Operating Expenses USD 23.711 Million
Comments
$Franklin Biotechnology Discovery Fund(LU0109394709.MF$
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences(KZR.US$ ... for biotech...
recently he just sold.
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences(KZR.US$ ... for biotech...
recently he just sold.
$Avinger(AVGR.US$ $Kezar Life Sciences(KZR.US$ watch these two stocks today, especially Kezar it's going to fly
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg